Market Overview:
The global spectral computed tomography (CT) market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for spectral CT in various applications such as pharmaceutical industries, research and development, medical research laboratories, academic medical institutes and universities. Additionally, the growing awareness about the benefits of spectral CT is also contributing to the growth of this market. North America dominates the global spectral computed tomography (CT) market followed by Europe and Asia Pacific.
 Industry Outlook.svg)
Product Definition:
Spectral computed tomography (CT) is an imaging technique that uses spectral information to improve the contrast of images. This technique can be used to differentiate between tissues with different densities, such as bone and muscle. Spectral CT may also be used to improve the detection of lesions and tumors.
Spiral CT:
Spiral CT is a type of Computed Tomography (CT) scan that produces high-quality cross-sectional images. It is also known as Helical Scanning or rotating an image capturing process. The technology was first developed in the 1980s and it has been evolving since then with various improvements and developments. Currently, spiral CT scanners are used to diagnose several diseases/conditions including but not limited to; cardiac disorders, gastrointestinal conditions, cancer & bone disorders among others.
Electron Beam Tomography:
Electron beam tomography is a type of X-ray imaging that utilizes an electron beam to obtain images of the internal structure. The technique was developed in the early 1970s and has been used extensively for research purposes since then. It provides high-resolution 3D images with minimal exposure time, which makes it ideal for clinical applications such as medical diagnosis and surgical planning.
Application Insights:
Based on application, the global market is segmented into pharmaceutical industries, research and development, medical research laboratories, academic medical institutes and universities. The pharmaceutical industries held the largest share of over 50% in 2017. This can be attributed to growing product usage for quality control in various processes such as drug discovery & development and manufacturing. Moreover, it also helps manufacturers to optimize their production capacity by identifying slow-moving or stationary items within a production line which requires additional CT imaging resources.
The research and development segment is expected to grow at a lucrative rate during the forecast period owing to increasing government funding for R&D activities across various countries including U.S.
Regional Analysis:
North America dominated the global market in 2017. The growth of this region can be attributed to the presence of major players, availability of advanced technologies and high adoption rate for technologically advanced products. Moreover, increasing cases of cancer has led to an increase in demand for CT scans across this region which is further expected to drive regional growth over the forecast period.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to factors such as improving healthcare infrastructure and growing medical tourism industry in countries such as India, China, Malaysia and Thailand among others. In addition, rising awareness about computed tomography amongst patients will also contribute towards regional growth over the next eight years.
Growth Factors:
- Increasing demand for minimally invasive surgeries: Spectral CT is widely used in minimally invasive surgeries as it offers high-resolution images with low radiation exposure. This is driving the growth of the spectral CT market.
- Growing demand for 3D and 4D imaging: The growing demand for 3D and 4D imaging is another major driver of the spectral CT market. Spectral CT offers high-resolution images with accurate color information, making it an ideal choice for 3D and 4D imaging applications.
- Rising prevalence of cancer: The rising prevalence of cancer is also fueling the growth of the spectral CT market as this technology can be used to detect early signs of cancer and help in its diagnosis and treatment planning.
- Increasing use of spectralCT in neurology: There has been a growing interest in using spectralCT in neurology due to its ability to image brain structures with high resolution, thereby helping clinicians diagnose various neurological disorders accurately. This is expected to drive the growthofthespectralCTmarketin thenear future . 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Spectral Computed Tomography (CT) Market Research Report
By Type
Spiral CT, Electron Beam Tomography, Multi-Slice Computed Tomography, Positron Emission Tomography (Pet), Single-Photon Emission Computed Tomography
By Application
Pharmaceutical Industries, Research and Development, Medical Research Laboratories, Academic Medical Institutes and Universities
By Companies
Fisher Scientific, Agilent Technologies, Koninklijke Philips, Neusoft Medical Systems, General Electric, Pall, Hitachi medical, Xoran Technologies, Varian Medical Systems, Trivitron Healthcare, Fisher Scientific, PerkinElmer, Bio-Rad Laboratories, Cleaver Scientific, NeuroLogica
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Spectral Computed Tomography (CT) Market Report Segments:
The global Spectral Computed Tomography (CT) market is segmented on the basis of:
Types
Spiral CT, Electron Beam Tomography, Multi-Slice Computed Tomography, Positron Emission Tomography (Pet), Single-Photon Emission Computed Tomography
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical Industries, Research and Development, Medical Research Laboratories, Academic Medical Institutes and Universities
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Fisher Scientific
- Agilent Technologies
- Koninklijke Philips
- Neusoft Medical Systems
- General Electric
- Pall
- Hitachi medical
- Xoran Technologies
- Varian Medical Systems
- Trivitron Healthcare
- Fisher Scientific
- PerkinElmer
- Bio-Rad Laboratories
- Cleaver Scientific
- NeuroLogica
 Market Overview.svg)
Highlights of The Spectral Computed Tomography (CT) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Spiral CT
- Electron Beam Tomography
- Multi-Slice Computed Tomography
- Positron Emission Tomography (Pet)
- Single-Photon Emission Computed Tomography
- By Application:
- Pharmaceutical Industries
- Research and Development
- Medical Research Laboratories
- Academic Medical Institutes and Universities
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Spectral Computed Tomography (CT) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Spectral computed tomography (CT) is a medical imaging technique that uses X-rays to create images of the inside of the body. CT scans are used to diagnose and treat a variety of health problems, including cancer, heart disease, and stroke.
Some of the major companies in the spectral computed tomography (ct) market are Fisher Scientific, Agilent Technologies, Koninklijke Philips, Neusoft Medical Systems, General Electric, Pall, Hitachi medical, Xoran Technologies, Varian Medical Systems, Trivitron Healthcare, Fisher Scientific, PerkinElmer, Bio-Rad Laboratories, Cleaver Scientific, NeuroLogica.
The spectral computed tomography (ct) market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Spectral Computed Tomography (CT) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Spectral Computed Tomography (CT) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Spectral Computed Tomography (CT) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Spectral Computed Tomography (CT) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Spectral Computed Tomography (CT) Market Size & Forecast, 2018-2028
4.5.1 Spectral Computed Tomography (CT) Market Size and Y-o-Y Growth
4.5.2 Spectral Computed Tomography (CT) Market Absolute $ Opportunity
Chapter 5 Global Spectral Computed Tomography (CT) Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Spectral Computed Tomography (CT) Market Size Forecast by Type
5.2.1 Spiral CT
5.2.2 Electron Beam Tomography
5.2.3 Multi-Slice Computed Tomography
5.2.4 Positron Emission Tomography (Pet)
5.2.5 Single-Photon Emission Computed Tomography
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Spectral Computed Tomography (CT) Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Spectral Computed Tomography (CT) Market Size Forecast by Applications
6.2.1 Pharmaceutical Industries
6.2.2 Research and Development
6.2.3 Medical Research Laboratories
6.2.4 Academic Medical Institutes and Universities
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Spectral Computed Tomography (CT) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Spectral Computed Tomography (CT) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Spectral Computed Tomography (CT) Analysis and Forecast
9.1 Introduction
9.2 North America Spectral Computed Tomography (CT) Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Spectral Computed Tomography (CT) Market Size Forecast by Type
9.6.1 Spiral CT
9.6.2 Electron Beam Tomography
9.6.3 Multi-Slice Computed Tomography
9.6.4 Positron Emission Tomography (Pet)
9.6.5 Single-Photon Emission Computed Tomography
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Spectral Computed Tomography (CT) Market Size Forecast by Applications
9.10.1 Pharmaceutical Industries
9.10.2 Research and Development
9.10.3 Medical Research Laboratories
9.10.4 Academic Medical Institutes and Universities
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Spectral Computed Tomography (CT) Analysis and Forecast
10.1 Introduction
10.2 Europe Spectral Computed Tomography (CT) Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Spectral Computed Tomography (CT) Market Size Forecast by Type
10.6.1 Spiral CT
10.6.2 Electron Beam Tomography
10.6.3 Multi-Slice Computed Tomography
10.6.4 Positron Emission Tomography (Pet)
10.6.5 Single-Photon Emission Computed Tomography
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Spectral Computed Tomography (CT) Market Size Forecast by Applications
10.10.1 Pharmaceutical Industries
10.10.2 Research and Development
10.10.3 Medical Research Laboratories
10.10.4 Academic Medical Institutes and Universities
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Spectral Computed Tomography (CT) Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Spectral Computed Tomography (CT) Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Spectral Computed Tomography (CT) Market Size Forecast by Type
11.6.1 Spiral CT
11.6.2 Electron Beam Tomography
11.6.3 Multi-Slice Computed Tomography
11.6.4 Positron Emission Tomography (Pet)
11.6.5 Single-Photon Emission Computed Tomography
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Spectral Computed Tomography (CT) Market Size Forecast by Applications
11.10.1 Pharmaceutical Industries
11.10.2 Research and Development
11.10.3 Medical Research Laboratories
11.10.4 Academic Medical Institutes and Universities
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Spectral Computed Tomography (CT) Analysis and Forecast
12.1 Introduction
12.2 Latin America Spectral Computed Tomography (CT) Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Spectral Computed Tomography (CT) Market Size Forecast by Type
12.6.1 Spiral CT
12.6.2 Electron Beam Tomography
12.6.3 Multi-Slice Computed Tomography
12.6.4 Positron Emission Tomography (Pet)
12.6.5 Single-Photon Emission Computed Tomography
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Spectral Computed Tomography (CT) Market Size Forecast by Applications
12.10.1 Pharmaceutical Industries
12.10.2 Research and Development
12.10.3 Medical Research Laboratories
12.10.4 Academic Medical Institutes and Universities
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Spectral Computed Tomography (CT) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Spectral Computed Tomography (CT) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Spectral Computed Tomography (CT) Market Size Forecast by Type
13.6.1 Spiral CT
13.6.2 Electron Beam Tomography
13.6.3 Multi-Slice Computed Tomography
13.6.4 Positron Emission Tomography (Pet)
13.6.5 Single-Photon Emission Computed Tomography
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Spectral Computed Tomography (CT) Market Size Forecast by Applications
13.10.1 Pharmaceutical Industries
13.10.2 Research and Development
13.10.3 Medical Research Laboratories
13.10.4 Academic Medical Institutes and Universities
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Spectral Computed Tomography (CT) Market: Competitive Dashboard
14.2 Global Spectral Computed Tomography (CT) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Fisher Scientific
14.3.2 Agilent Technologies
14.3.3 Koninklijke Philips
14.3.4 Neusoft Medical Systems
14.3.5 General Electric
14.3.6 Pall
14.3.7 Hitachi medical
14.3.8 Xoran Technologies
14.3.9 Varian Medical Systems
14.3.10 Trivitron Healthcare
14.3.11 Fisher Scientific
14.3.12 PerkinElmer
14.3.13 Bio-Rad Laboratories
14.3.14 Cleaver Scientific
14.3.15 NeuroLogica
